Apofore
Latest round
- Series A
Last raised
- Jul 2011
Total raised
- $0.5M
Investors
- 1
About Apofore
Apofore develops novel therapeutics for Type 2 diabetes based on the naturally occurring protein, Apolipoprotein A-IV (apo A-IV).
Who invested in Apofore
1 investor across 1 round
See all investors in Apofore
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 28, 2011
Amount
$0.5M
Investors
Questions about Apofore
Who invested in Apofore?
Apofore has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apofore raised?
Apofore has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Apofore last raise money?
Apofore's most recent round on record is a Series A, in Jul 2011.
What does Apofore do?
Apofore develops novel therapeutics for Type 2 diabetes based on the naturally occurring protein, Apolipoprotein A-IV (apo A-IV).
Where is Apofore headquartered?
Apofore is headquartered in Cambridge, US.
Which VCs invest in companies like Apofore?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Apofore's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Apofore? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.